Imibact® (Imibact®)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceHydroxymethylquinoxaline dioxideHydroxymethylquinoxaline dioxide
Similar drugsTo uncover
  • Viuxidin®
    concentrate d / infusion 
    TRIVIUM-XXI, LLC     Russia
  • Dixin
    solution c / cavity externally 
    ATOLL, LLC     Russia
  • Dioxydin®
    solution d / infusion externally 
    VALENTA PHARM, PAO     Russia
  • Dioxydin
    solution c / cavity externally 
    BIOSINTEZ, PAO     Russia
  • Dioxydin
    ointment externally 
    BIOSINTEZ, PAO     Russia
  • Dioxydin®
    ointment cutaneous externally 
    NIZHFARM, JSC     Russia
  • Dioxydin
    solution in / in 
    MOSHIMFARM PREPARATES them. N.А.Semashko, OJSC     Russia
  • Imibact®
    solution c / cavity externally 
    SYNTHESIS, OJSC     Russia
  • Imibact®
    solution locally in / in externally 
    SYNTHESIS, OJSC     Russia
  • Imibact®
    ointment locally externally 
    SYNTHESIS, OJSC     Russia
  • Urotravenol
    solution v / vesular 
    MTS MEDICINE, LLC     Russia
    • Dosage form: & nbspointment for topical and topical application
    ATX: & nbsp

    J.01.X.X   Other antibacterial drugs

    Terms of leave from pharmacies:On prescription
    Registration number:LP-004639
    Date of registration:17.01.2018
    Expiration Date:17.01.2023
    The owner of the registration certificate:SYNTHESIS, OJSC SYNTHESIS, OJSC Russia
    Manufacturer: & nbsp
    Illustrated instructions
      Instructions
      Up